Improving medication adherence for Black women with breast cancer using mobile health tools
Official title: Developing a culturally tailored mHealth symptom monitoring intervention to improve adherence to endocrine therapy among Black women with breast cancer
Funded at University of Pennsylvania · NIH-10930838 · Data updated 2026-11-12
This study is all about helping Black women with breast cancer stick to their hormone therapy by using a mobile health program that fits their unique needs and preferences, making it easier for them to manage symptoms and get the support they deserve.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | September 18, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $284,386 |
| NIH project number | 7K08CA279076-02 |
| Project ID | NIH-10930838 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Black women diagnosed with breast cancer who are undergoing endocrine therapy.
✕Less likely to help
Patients who are not Black or those who are not undergoing endocrine therapy for breast cancer may not benefit from this research.
What this research studies
This research focuses on creating a mobile health intervention specifically designed to help Black women with breast cancer adhere to their endocrine therapy. By tailoring the intervention to the cultural needs and preferences of this population, the project aims to enhance the effectiveness of treatment through better symptom monitoring and support. The approach includes training and mentorship in developing behavioral interventions, ensuring that the methods used are both scientifically sound and culturally relevant. Patients will be engaged in the process to ensure their needs are met and to improve overall health outcomes.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment adherence and better health outcomes for Black women with breast cancer.
How similar studies have gone: Previous research has shown success in using culturally tailored interventions to improve health outcomes in minority populations, suggesting a promising approach for this project.
Where this research is happening
-
University of Pennsylvania
Philadelphia, United States Active
Researchers
- Principal investigator: Lee, Kimberley T — University of Pennsylvania
- Study coordinator: Lee, Kimberley T
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genomic study to understand how genetics and epigenetics shape triple-negative breast cancer in African ancestry
This study looks at how inherited genes and gene activity affect triple-negative breast cancer in people of African ancestry to better understand why outcomes can be worse.
-
Translational breast cancer research to improve treatment options
A comprehensive program at Baylor College of Medicine is focusing on breast cancer; researchers will advance targeted therapies and biomarkers to help patients with aggressive or hard-to-treat forms.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Co-Targeting IL-6 and CDK4/6 to Prevent TNBC in Women Veterans
A study aims to block two cancer-promoting pathways (IL-6 and CDK4/6) to prevent or reduce progression of triple-negative breast cancer in women veterans.
-
Gut bacteria and metabolites linked to breast density and cancer risk
A small, patient-friendly study will explore whether gut bacteria and their byproducts are connected to high breast density, which can raise cancer risk and make screening less accurate.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.